09/01/2024 | Press release | Distributed by Public on 09/01/2024 09:57
Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2024. It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 (0)6 61 40 18 84
Email: [email protected]
The hashtag for ESC Congress 2024 is #ESCCongress
Follow us on X @ESCardioNews
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
Funding: None
Disclosures: Gianluca Campo received institutional unconditioned research grants from SMT, Medis, Siemens, GE and Eukon for the conduction of the FIRE trial.
References and notes
1'EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients' will be discussed during Hot Line 8 on Sunday 1 September in room London.
2Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381:1411-1421.
3Biscaglia S, Guiducci V, Escaned J, et al. Complete or culprit-only PCI in older patients with myocardial infarction. N Engl J Med. 2023;389:889-898.
4Böhm F, Mogensen B, Engstrøm T, et al. FFR-guided complete or culprit-only PCI in patients with myocardial infarction. N Engl J Med. 2024;390:1481-1492.
5Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665-671.
6Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234-1244.
7Hamza M, Mahmoud N, Elgendy IY. A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease. J Interv Cardiol. 2016;29:241-247.
8Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963-972.
It is the world's largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in London and online - from 30 August to 2 September. Explore the scientific programme. More information is available from the ESC Press Office at [email protected].
About the European Society of Cardiology
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.